The complete roster

All twenty-six pieces in one table, with the section each belongs to. This is the dense form; the section pages are the edited ones.

Piece	Section	Subject
30C Written Out	The Pharmacy	Presents the dilution factor for a 30C preparation — 10⁻⁶⁰ — as worked arithmetic, showing each step of the centesimal series and where Avogadro's limit falls within it.
Avogadro's Hypothesis, and the Number That Came Later	The Pharmacy	Covers Avogadro's 1811 paper, the subsequent measurement of the constant by later chemists, and how 6.022 × 10²³ became the figure against which homeopathic dilutions are compared.
C, X, and What the Letters Mean on the Label	The Pharmacy	Explains the centesimal (C) and decimal (X) dilution scales, their notational conventions, and what a given number on a product label translates to in powers of ten.
Single-Vial Method, Different Arithmetic	The Pharmacy	Describes Korsakov's single-vial dilution method — retained in HPUS alongside multi-vial centesimal preparation — and shows how the assumed dilution factor differs from the standard calculation.
From the Mother Tincture to the Pillule	The Pharmacy	A walk-through of the production sequence: the starting material, the mother tincture, succussion, serial dilution, and the lactose or sucrose pillule as the final carrier.
The Cinchona Bark, the Fever, and the Self-Experiment of 1796	Hahnemann	Hahnemann's 1796 self-administration of Peruvian bark and its place in the formation of similia similibus curentur — drawn from his own account in the Hufeland's Journal paper of that year.
Six Editions, One Argument Revised	Hahnemann	Tracks the Organon der rationellen Heilkunde from its first edition (1810) through the posthumous sixth (1921), noting what changed between editions — the introduction of LM potencies, the development of the miasm theory — and how each is cited by later institutions.
The Leipzig Provings and the Materia Medica Pura	Hahnemann	Describes the proving methodology Hahnemann developed in Leipzig, the publication of the Materia Medica Pura (1811–21) and the Chronic Diseases (1828), and the role the proving circle played in generating the remedy record.
Allopathy: Who Coined It and What It Was Meant to Mean	Hahnemann	A short piece on the term 'allopathy' as Hahnemann's own coinage from around 1810, its original meaning in his system, and how it passed into broader use.
Père Lachaise, Division 22	Hahnemann	The monument to Hahnemann (1755–1843) at Père Lachaise cemetery in Paris — its location, the inscription it carries, and how it was established.
Rotterdam, 1925: How the LMHI Was Constituted	Institutions	The founding of the Liga Medicorum Homoeopathica Internationalis in Rotterdam in 1925, its stated purpose, its congress series, and the 70th congress held in Rio de Janeiro in 2015 — the year this domain is named for.
The Faculty of Homeopathy, Chartered 1844	Institutions	The Faculty of Homeopathy's foundation in London in 1844, its royal charter, its relationship to the Royal London Homoeopathic Hospital, and its role in postgraduate qualification.
The Building on Great Ormond Street, and Its Two Names	Institutions	The Royal London Homoeopathic Hospital from its nineteenth-century founding through its 2010 renaming as the Royal London Hospital for Integrated Medicine — the building, the NHS trust, and the name change documented from official sources.
Hahnemann Medical College, Philadelphia, 1833	Institutions	Constantine Hering's founding of the Homoeopathic Medical College of Pennsylvania in Philadelphia in 1848 (chartered 1867 as Hahnemann), its later history, and its place as the first such institution in the United States.
Three Manufacturers and Their Founding Dates	Institutions	Boiron (founded Lyon, 1932), Weleda (founded Arlesheim, 1921) and Heel (founded Baden-Baden, 1936) as the principal named manufacturers — their founding, their pharmacopoeial reference standards, and their regulatory registrations.
Two Pharmacopoeias and What They Regulate	Institutions	A comparison of the Homeopathic Pharmacopoeia of the United States (HPUS) and the German Hufelandverzeichnis — what each document covers, how a substance enters each list, and the regulatory bodies that reference them.
Australia's NHMRC Read 176 Papers and Published What It Found	The Reviews	The Australian National Health and Medical Research Council's 2015 systematic review — its scope (176 studies, 68 health conditions), its methodology, its conclusions as stated in the published document, and the earlier 2012 draft and its handling.
The Commons Committee Called It Evidence Check 2	The Reviews	The House of Commons Science and Technology Committee's 2010 Evidence Check inquiry — the oral evidence sessions, the witnesses named, the committee's published conclusions, and the government's formal response.
Shang in The Lancet, and the Argument About Which Trials Counted	The Reviews	Aijing Shang et al.'s 2005 Lancet meta-analysis — the 110 homeopathy trials and 110 matched conventional trials examined, the 'high quality' subset that drove the conclusions, and the published correspondence that disputed the trial selection.
Linde in The Lancet, Eight Years Earlier	The Reviews	Klaus Linde et al.'s 1997 Lancet meta-analysis, its conclusions, and the 1999 reanalysis by the same lead author that revised them — both attributed, both dated, the revision presented without editorial comment.
Benveniste's Paper, and What Nature Did Next	The Reviews	Jacques Benveniste's 1988 Nature paper on high-dilution effects on basophil degranulation — the paper itself, the editorial note Nature attached, and the supervised replication reported in the same journal that failed to confirm the findings.
The Swiss PEK Report, and the Dispute Over Its Authorship	The Reviews	The 2006 Swiss Programm Evaluation Komplementärmedizin report — what it examined, what the Swiss government commission found, and the documented dispute over whether the final published version reflected what the review authors submitted.
The FTC Wrote an Enforcement Policy, and It Changed the Packaging	The Documents	The US Federal Trade Commission's November 2016 enforcement policy statement on homeopathic product claims — what it requires on labels, the 'competent and reliable scientific evidence' standard, and examples of the disclosure language it mandated.
NHS England Consulted in 2017, Then Stopped Routine Funding in 2018	The Documents	The NHS England consultation on items of low clinical value (July 2017) — homeopathy's inclusion, the volume of responses, the final guidance published in November 2017, and the end of routine CCG funding that followed in 2018.
France Announced in 2019, and the Last Reimbursements Fell in 2021	The Documents	The French Haute Autorité de Santé's 2019 assessment, the government announcement of the phased withdrawal of Sécurité Sociale reimbursement for homeopathic products, and the completion of that withdrawal in 2021.
The European Academies Science Advisory Council, 2017	The Documents	EASAC's 2017 statement on homeopathic products — the member academies who endorsed it, its scope, and the specific regulatory recommendations it directed at EU institutions.